Cree, Bruce A. C.
Article History
First Online: 16 December 2014
Competing interests
: B.C. has received personal compensation for consulting from Abbvie, Biogen Idec, EMD Serono, Genzyme/Sanofi Aventis, MedImmune, Novartis and Teva Neurosciences. He has received research support (including for clinical trials) from Acorda, Avanir, Biogen Idec, EMD Serono, Hoffman La Roche, MedImmune and Teva Neurosciences.